Magnificent Seven: What do you need to believe?

by David Polak, Equity Investment Director, Capital Group

The Magnificent Seven stocks — Alphabet, Amazon, Apple, Meta, Microsoft, Nvidia and Tesla — now sport a market cap of around $12 trillion (in U.S. dollar terms). Looking further into the market, the sales and profitability of the next $12 trillion in market cap are represented by 42 companies from a broad set of industries ranging from tech and health care to financials and consumer companies.

 

Can the Magnificent Seven maintain their dominance?

The bar chart shows a comparison of Magnificent Seven stocks – Apple, Microsoft, Amazon, Nvidia, Alphabet, Tesla and Meta. This group is compared to the next 42 companies in the S&P 500 that have an equivalent market cap of the mega-cap tech group. Leaders of this group ranked by market capitalization include Berkshire Hathaway, Broadcom, JPMorgan Chase, UnitedHealth and Eli Lilly. The bar graph compares market value, sales and profit. The market value of the Magnificent Seven is $12.04 trillion compared to the next 42 companies at $12.06 trillion. Sales for the Magnificent Seven are about $1.7 trillion, and the next 42 companies are $4.4 trillion. For profit, the Magnificent Seven boasts about $358 billion versus the next 42 companies at $714 billion. Values are in USD.

Sources: Capital Group, LSEG. Next 42 companies represent stocks following the Magnificent Seven, ranked by market capitalization, with the above stocks topping the list. Sales are the net sales (or revenues) of the relevant item reported in the last 12 months. Profit is represented by the trailing 12-month operating profit. As of December 31, 2023. Values are in USD.

Both the 12-month forward sales and earnings for this next set of companies making up a $12 trillion market cap are higher than for the Magnificent Seven, according to London Stock Exchange Group (LSEG) data as of December 31, 2023 — yet another data point indicating U.S. stock market performance could broaden in the coming years, pending earnings outlooks.

Our focus remains on valuations given the rise in share prices for the Magnificent Seven. The S&P 500 Index has a forward price-to-earnings (P/E) ratio of about 15.5x excluding the Magnificent Seven, while the Magnificent Seven has a P/E of about 35x, according to data compiled by FactSet as of January 2, 2024. Earnings growth estimates in 2024 bring the division into high relief — the Magnificent Seven boasts 20.8%, with the S&P 500 at 11.5%, and S&P 500 sans-Magnificent Seven at 6.7%, respectively. For 2025, earnings growth estimates for those three groups are projected at about 17%, 12% and 6.7%, respectively. Longer term earnings estimates for the M7 remain higher, but the uncertainty band around them would also be higher. Hence, the need to diversify.

There’s a strong case to be made for the companies apart from their stock performance. The Bloomberg Magnificent 7 Total Return Index advanced 107% in 2023 versus the overall S&P 500 Index at 24%, largely because the positive fundamentals more than offset headwinds from rising interest rates. In 2023, these companies implemented stronger cost discipline through headcount reductions and capital reallocation to more profitable projects.

Sound balance sheets and strong cash generation give the Magnificent Seven an edge to invest in research and development, while also investing in artificial intelligence (AI) to potentially drive growth in the coming years. Last year, these companies in aggregate spent over $170 billion in capital expenditures and over $200 billion on research and development on initiatives that might have a secular impact on the economy, such as AI applications.

Risks to the group include elevated investor expectations after strong earnings in a choppy economic environment. Additionally, signs of global economic weakness could impact certain big-cap tech stocks more than others. Heightened geopolitical tensions and regulatory questions may also linger throughout 2024.

Nevertheless, investors may want to consider some exposure to the Magnificent Seven and also a broader set of stocks within the S&P 500 — as well as non-U.S. markets, where in some cases valuations are reasonable and prospects for both top-line and bottom-line growth look promising.

Read more:

Risks of bad breadth: Market concentration in 5 charts 


David Polak is an equity investment director with 39 years of experience (as of 12/31/2022).  He holds a bachelor’s degree in economics from University College London graduating with honors.

 

Copyright © Capital Group

Total
0
Shares
Previous Article

Do Valuations Matter?

Next Article

Seven reasons to be optimistic about the global economy

Related Posts
Subscribe to AdvisorAnalyst.com notifications
Watch. Listen. Read. Raise your average.